Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001849958 | SCV002229334 | pathogenic | Severe neonatal-onset encephalopathy with microcephaly | 2021-10-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp104*) in the MECP2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MECP2 are known to be pathogenic (PMID: 12180070). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with MECP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 143530). For these reasons, this variant has been classified as Pathogenic. |
Centre for Population Genomics, |
RCV000133062 | SCV004101611 | likely pathogenic | Rett syndrome | 2023-10-12 | criteria provided, single submitter | curation | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 2.0, this variant is classified as likely pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). This variant is absent from gnomAD (PM2_Supporting). |
Rett |
RCV000133062 | SCV000188050 | pathogenic | Rett syndrome | 2006-02-03 | no assertion criteria provided | curation |